Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma
- PMID: 15515571
Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma
Abstract
Thymidine kinase (TK) is a cellular enzyme which is involved in a 'salvage pathway' of DNA synthesis. It is activated in the G1/S phase of the cell cycle, and its activity has been shown to correlate with the proliferative activity of tumor cells.... Clinical studies have reported high serum TK concentrations in a variety of neoplasias. The majority of these studies concerned hematological malignancies. TK seems to be a useful marker in non-Hodgkin's lymphoma, where it correlates with clinical staging and provides marked prognostic information on (progression-free) survival.
Comment on
-
Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.J Vet Intern Med. 2004 Sep-Oct;18(5):696-702. doi: 10.1892/0891-6640(2004)18<696:stkaid>2.0.co;2. J Vet Intern Med. 2004. PMID: 15515587
Similar articles
-
Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.Ann Hematol. 1992 Jul;65(1):1-5. doi: 10.1007/BF01715117. Ann Hematol. 1992. PMID: 1643153 Review.
-
Plasma thymidine kinase activity in dogs with lymphoma and leukemia.J Vet Med Sci. 1997 Oct;59(10):957-60. doi: 10.1292/jvms.59.957. J Vet Med Sci. 1997. PMID: 9362053
-
A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.Res Vet Sci. 2006 Feb;80(1):17-24. doi: 10.1016/j.rvsc.2005.05.001. Epub 2005 Sep 2. Res Vet Sci. 2006. PMID: 16140350
-
Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.J Vet Intern Med. 2004 Sep-Oct;18(5):696-702. doi: 10.1892/0891-6640(2004)18<696:stkaid>2.0.co;2. J Vet Intern Med. 2004. PMID: 15515587
-
Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.Vet Comp Oncol. 2011 Mar;9(1):1-15. doi: 10.1111/j.1476-5829.2010.00238.x. Epub 2010 Aug 19. Vet Comp Oncol. 2011. PMID: 21303450 Review.
Cited by
-
Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.J Vet Intern Med. 2016 Jul;30(4):1159-66. doi: 10.1111/jvim.13954. Epub 2016 May 23. J Vet Intern Med. 2016. PMID: 27214230 Free PMC article.
-
Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma.Tumour Biol. 2013 Apr;34(2):643-8. doi: 10.1007/s13277-012-0591-0. Epub 2012 Nov 21. Tumour Biol. 2013. PMID: 23179401
-
Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer.Exp Ther Med. 2012 Feb;3(2):331-335. doi: 10.3892/etm.2011.395. Epub 2011 Nov 28. Exp Ther Med. 2012. PMID: 22969891 Free PMC article.
-
Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer.Ups J Med Sci. 2009;114(2):116-20. doi: 10.1080/03009730802688835. Ups J Med Sci. 2009. PMID: 19396699 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources